Coronavirus: These are the prices of vaccines – They were published by mistake by the Belgian Deputy Minister



[ad_1]

Belgium’s Undersecretary of State for the Budget mistakenly posted a tweet indicating the price of each coronavirus vaccine purchased by the EU.

The prices of the vaccines bought by the European Union are secret. The Commission has repeatedly stated that it cannot disclose the prices paid for each coronavirus vaccine, citing confidentiality trade agreements. Citizen groups, MEPs and transparency advocates have been urging the Commission for months to reveal how much the EU pays, arguing that tax fund arrangements need to be more transparent. However, the prices of the vaccines were kept strictly secret.

All this until yesterday. And this is because Belgium’s Under Secretary of State for Budget Eva De Bleeker tweeted on Thursday revealing, reluctantly and reluctantly, the price of each vaccine purchased by the EU. and how much Belgium will spend in total on vaccines. The tweet was deletedhowever, the Dutch-language journalistic website HLN “kept it”.

According to the print screen published by HLN, the EU costs between € 1.78 and $ 18 per coronavirus vaccine. The value per dose reported for each of the six vaccines was as follows:

  • BioNTech / Pfizer: € 12
  • Modern: $ 18
  • Oxford / AstraZeneca: € 1.78
  • Johnson & Johnson: $ 8.50
  • Sanofi / GSK: € 7.56
  • CureVac: € 10

the Belgium will buy more than 33 million vaccines for a total of 279 million. De Blacker said the release of the price breakdown was “a mistake on the part of his team,” according to HLN. For the record, the Commission yesterday concluded a preliminary agreement with another company, 7, called Novavax.

The effectiveness of vaccines.

Apart from the prices of vaccines, what worries citizens and above all the scientific community is the effectiveness of the preparations that are available today. According to the results of the clinical trials of each company, it is as follows:

  • Modern: 95%
  • Pfizer / BioNTech: 95%
  • AstraZeneca (Oxford): 70%
  • Russian Sputnik V vaccine (no agreement with the EU): 96.2%
[ad_2]